Short pulses of low-energy laser light create better medical images

Detection and treatment of tumours, diseased blood vessels and other soft-tissue conditions could be significantly improved, thanks to an innovative imaging system being developed that uses both light and sound.

The system uses extremely short pulses of low-energy laser light to stimulate the emission of ultrasonic acoustic waves from the tissue area being examined. These waves are then converted into high-resolution 3D images of tissue structure.

This method can be used to reveal disease in types of tissue that are more difficult to image using techniques based on x-rays or conventional ultrasound. For example, the new system is better at imaging small blood vessels, which may not be picked up at all using ultrasound. This is important in the detection of tumours, which are characterised by an increased density of blood vessels growing into the tissue.

The technique, which is completely safe, will help doctors diagnose, monitor and treat a wide range of soft-tissue conditions more effectively.

The first of its kind in the world, the prototype system has been developed by medical physics and bioengineering experts at University College London, with funding from the Engineering and Physical Sciences Research Council (EPSRC). It is soon to undergo trials in clinical applications, with routine deployment in the healthcare sector envisaged within around 5 years.

The emission of an acoustic wave when matter absorbs light is known as the photoacoustic effect. Harnessing this basic principle, the new system makes use of the variations in the sound waves that are produced by different types of soft human tissue to identify and map features that other imaging methods cannot distinguish so well.

By appropriate selection of the wavelength of the laser pulses, the light can be controlled to penetrate up to depths of several centimetres. The technique therefore has important potential for the better imaging of conditions that go deep into human tissue, such as breast tumours, and for contributing to the diagnosis and treatment of vascular disease.

The prototype instrument, however, has been specifically designed to image very small blood vessels (with diameters measured in tens or hundreds of microns) that are relatively close to the surface. Information generated about the distribution and density of these microvessels can in turn provide valuable data about skin tumours, vascular lesions, burns, other soft tissue damage, and even how well an area of tissue has responded to plastic surgery following an operation.

The development process has included theoretical and experimental investigations of photoacoustic interactions with soft tissue, development of appropriate computer image-reconstruction algorithms, and construction of a prototype imaging instrument incorporating the new technique.

“This new system offers the prospect of safe, non-invasive medical imaging of unprecedented quality,” says Dr Paul Beard who leads UCL’s Photoacoustic Imaging Group. “It also has the potential to be an extremely versatile, relatively inexpensive and even portable imaging option.”

Keywords: Medical, Technology, Physics

Notes for editors: The nanosecond pulses of laser light used by the new system are of near-infrared wavelength. The light causes the target tissue to undergo a tiny rise in temperature and a tiny expansion, both of which contribute to the generation of a small ultrasonic acoustic wave. Ultrasonic acoustic waves have frequencies above 20 kilohertz (the normal range of human hearing). NB. The new system generates waves in the range from 1 – 50 MHz.

With conventional ultrasound, a pulse of sound is transmitted into an area of tissue, which generates a signal that is reflected back and used to construct an image. However, when examining very small blood vessels, the size of the ultrasound signal reflected back is very small. This is because the mechanical and elastic properties of blood vessels are similar to those of the surrounding tissue, making them difficult to distinguish from each other. (It is the mechanical and elastic properties that the ultrasound is imaging.) In contrast, photoacoustic imaging is based on a very different mechanism, in that it uses the absorption of light to generate a signal (specifically, a sound wave). The reason that this technique is so good at imaging blood vessels in particular is that haemoglobin in the blood absorbs light very strongly, producing a large signal.

The design of the current prototype instrument is optimised for imaging close to the surface with high spatial resolution*. This is a consequence of the completely new type of optical detector that has been developed for use in the prototype system**. The technique is also capable of imaging deeper (to several centimetres) if piezoelectric detectors are used instead. However, this comes at a cost of reduced spatial resolution.

* Spatial resolution refers to the sharpness of an image, i.e. how well the edges of the objects shown are defined.

**The prototype instrument is the first of its kind in the world, because of the completely new type of detector it uses, which employs optical means to detect the photoacoustic signal. This enables the system to generate high-resolution images of superficial tissues.

The new technique is less well suited to imaging bone. Bone’s hard surface can cause strong reflections of acoustic waves, which can lead to the creation of ghost images. Moreover, if trying to image through bone (e.g. the skull), a significant proportion of the sound energy will be reflected; this will reduce the detected signals.

The new technique draws on capabilities developed in the course of a number of EPSRC-funded initiatives in recent years. Some initiatives are now complete, while the following are still in progress:

  • “Development of novel optical and photoacoustic instruments for clinical diagnosis and monitoring”, 2005-10, £423,328
  • “Development of a 3D photoacoustic scanner for in vivo high resolution anatomical, physiological and molecular imaging”, 2005-09, £571,267
  • “Multispectral quantitative image reconstruction methods for photoacoustic molecular imaging”, 2006-09, £327,327

An algorithm is a computer programme that involves a logical sequence of steps designed to solve a particular problem and calculate an answer.

The photoacoustic effect was first noticed by Alexander Graham Bell (the inventor of the telephone) in the late 19th Century.

The Engineering and Physical Sciences Research Council (EPSRC) is the UK's main agency for funding research in engineering and the physical sciences. The EPSRC invests around £740 million a year in research and postgraduate training, to help the nation handle the next generation of technological change. The areas covered range from information technology to structural engineering, and mathematics to materials science. This research forms the basis for future economic development in the UK and improvements for everyone's health, lifestyle and culture. EPSRC also actively promotes public awareness of science and engineering. EPSRC works alongside other Research Councils with responsibility for other areas of research. The Research Councils work collectively on issues of common concern via Research Councils UK.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Spermidine regulates RIPK1 to combat diabetes and vascular damage